Back to Journals » OncoTargets and Therapy » Volume 6

Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers

Total article views   Abstract views HTML views PDF downloads Totals
13,260 Dovepress* 8,441 774+ 2,749 9,215
PubMed Central* 10 4,035 1,596 4,045
Totals 8,451 4,809 4,345 13,260
*Since 5 November 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed Central and Google Scholar